Literature DB >> 15012588

Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor.

Line V Hansen1, Henrik Gårdsvoll, Boye S Nielsen, Leif R Lund, Keld Danø, Ole N Jensen, Michael Ploug.   

Abstract

C4.4A, a structural homologue of the urokinase-type plasminogen activator receptor (uPAR), was originally identified as a metastasis-associated membrane protein, but little is known about its structural and functional properties. Therefore, we expressed, purified and characterized a soluble truncated form of human C4.4A, and used this protein to produce specific polyclonal anti-C4.4A antibodies. By immunohistochemistry we observed a pronounced surface staining for C4.4A in suprabasal keratinocytes of chronic human wounds and found C4.4A expression markedly upregulated in migrating keratinocytes during re-epithelisation of incisional skin wounds. Phorbol-ester-induced hyperplasia of mouse skin is also accompanied by a significant induction of C4.4A expression in the multilayered, suprabasal keratinocytes. C4.4A contains two Ly-6 (leucocyte antigen 6)/uPAR/alpha-neurotoxin modules. Our recombinant human C4.4A is extensively modified by post-translational glycosylation, which include 5-6 N-linked carbohydrates primarily located in or close to its second Ly-6/uPAR/alpha-neurotoxin module and approximately 15 O-linked carbohydrates clustered in a Ser/Thr/Pro-rich region at the C-terminus. A highly protease-sensitive region (Tyr200-Arg204) is located between these two clusters of N- and O-linked carbohydrates. The natural, glycolipid-anchored C4.4A from amnion membranes of human term placenta exhibits similar properties. Using recombinant, soluble C4.4A or MCF 7 cells, which express significant amounts of GPI-anchored C4.4A, we find no evidence for an interaction between C4.4A and uPA, a property suggested previously for rat C4.4A. Collectively these data indicate that C4.4A, although being a structural homologue of uPAR, is unlikely to have a functional overlap with uPAR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15012588      PMCID: PMC1224211          DOI: 10.1042/BJ20031478

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  O-GLYCBASE Version 3.0: a revised database of O-glycosylated proteins.

Authors:  J E Hansen; O Lund; J Nilsson; K Rapacki; S Brunak
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

2.  Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.

Authors:  C Holst-Hansen; B Johannessen; G Høyer-Hansen; J Rømer; V Ellis; N Brünner
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

3.  Structure-function relationships of the complement regulatory protein, CD59.

Authors:  J Petranka; J Zhao; J Norris; N B Tweedy; R E Ware; P J Sims; W F Rosse
Journal:  Blood Cells Mol Dis       Date:  1996       Impact factor: 3.039

4.  Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins.

Authors:  M Ploug; M Kjalke; E Rønne; U Weidle; G Høyer-Hansen; K Danø
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

Review 5.  Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins.

Authors:  M Ploug; V Ellis
Journal:  FEBS Lett       Date:  1994-08-01       Impact factor: 4.124

Review 6.  How glycosylphosphatidylinositol-anchored membrane proteins are made.

Authors:  S Udenfriend; K Kodukula
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

7.  Generation and characterization of urokinase receptor-deficient mice.

Authors:  M Dewerchin; A V Nuffelen; G Wallays; A Bouché; L Moons; P Carmeliet; R C Mulligan; D Collen
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

8.  The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria.

Authors:  M Ploug; T Plesner; E Rønne; V Ellis; G Høyer-Hansen; N E Hansen; K Danø
Journal:  Blood       Date:  1992-03-15       Impact factor: 22.113

9.  The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility.

Authors:  T H Bugge; T T Suh; M J Flick; C C Daugherty; J Rømer; H Solberg; V Ellis; K Danø; J L Degen
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

10.  Differential expression of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse skin after exposure to a tumor-promoting phorbol ester.

Authors:  L R Lund; J Eriksen; E Ralfkiaer; J Rømer
Journal:  J Invest Dermatol       Date:  1996-04       Impact factor: 8.551

View more
  28 in total

1.  C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer.

Authors:  Ryota Oshiro; Hirofumi Yamamoto; Hidekazu Takahashi; Masahisa Ohtsuka; Xin Wu; Junichi Nishimura; Ichiro Takemasa; Tsunekazu Mizushima; Masataka Ikeda; Mitsugu Sekimoto; Nariaki Matsuura; Yuichiro Doki; Masaki Mori
Journal:  Cancer Sci       Date:  2012-04-11       Impact factor: 6.716

2.  The urokinase receptor homolog Haldisin is a novel differentiation marker of stratum granulosum in squamous epithelia.

Authors:  Henrik Gårdsvoll; Mette C Kriegbaum; Emil P Hertz; Warner Alpízar-Alpízar; Michael Ploug
Journal:  J Histochem Cytochem       Date:  2013-07-29       Impact factor: 2.479

3.  Did evolution create a flexible ligand-binding cavity in the urokinase receptor through deletion of a plesiotypic disulfide bond?

Authors:  Julie M Leth; Haydyn D T Mertens; Katrine Zinck Leth-Espensen; Thomas J D Jørgensen; Michael Ploug
Journal:  J Biol Chem       Date:  2019-03-20       Impact factor: 5.157

4.  GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia.

Authors:  Xuchen Hu; Geesje M Dallinga-Thie; G Kees Hovingh; Sandy Y Chang; Norma P Sandoval; Tiffany Ly P Dang; Isamu Fukamachi; Kazuya Miyashita; Katsuyuki Nakajima; Masami Murakami; Loren G Fong; Michael Ploug; Stephen G Young; Anne P Beigneux
Journal:  J Clin Lipidol       Date:  2017-06-13       Impact factor: 4.766

5.  Membrane-bound and exosomal metastasis-associated C4.4A promotes migration by associating with the α(6)β(4) integrin and MT1-MMP.

Authors:  Honoré Ngora; Uwe M Galli; Kaoru Miyazaki; Margot Zöller
Journal:  Neoplasia       Date:  2012-02       Impact factor: 5.715

6.  The non-phagocytic route of collagen uptake: a distinct degradation pathway.

Authors:  Daniel H Madsen; Signe Ingvarsen; Henrik J Jürgensen; Maria C Melander; Lars Kjøller; Amanda Moyer; Christian Honoré; Charlotte A Madsen; Peter Garred; Sven Burgdorf; Thomas H Bugge; Niels Behrendt; Lars H Engelholm
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

7.  Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide.

Authors:  Paola Llinas; Marie Hélène Le Du; Henrik Gårdsvoll; Keld Danø; Michael Ploug; Bernard Gilquin; Enrico A Stura; André Ménez
Journal:  EMBO J       Date:  2005-04-07       Impact factor: 11.598

8.  Epithelial progenitor 1, a novel factor associated with epithelial cell growth and differentiation.

Authors:  Marcie R Kritzik; Cory U Lago; Ayse G Kayali; Sandrine Arnaud-Dabernat; Guoxun Liu; You-Qing Zhang; Hong Hua; Howard S Fox; Nora E Sarvetnick
Journal:  Endocrine       Date:  2010-01-09       Impact factor: 3.633

9.  Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.

Authors:  Julie M Kneller; Thomas Ehlen; Jasenka P Matisic; Dianne Miller; Dirk Van Niekerk; Wan L Lam; Marco Marra; Rebecca Richards-Kortum; Michelle Follen; Calum Macaulay; Steven J M Jones
Journal:  Biomark Insights       Date:  2007-12-11

Review 10.  C4.4A as a biomarker of head and neck squamous cell carcinoma and correlated with epithelial mesenchymal transition.

Authors:  Jian-Feng Liu; Liang Mao; Lin-Lin Bu; Si-Rui Ma; Cong-Fa Huang; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.